Hospital costs fell as numbers of LVADs were increasing: experiences from Oslo University Hospital

Journal of Cardiothoracic Surgery

Volumn 7, Issue 1, 2012, Pages

  Mishra, Vinod ^a,d   Fiane, Arnt E ^a,b   Geiran, Odd ^a,b   Sørensen, Gro ^a   Khushi, Ishtiaq ^c   Hagen, Terje P ^d  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c AKERSHUS UNIVERSITY HOSPITAL   (Norway)

^d UNIVERSITY OF OSLO   (Norway)

Author keywords

Cost analysis; DRG reimbursement; Hospital cost; Innovative technology; Left ventricle assist device

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; ECONOMICS; FEMALE; HEART ASSIST DEVICE; HEART SURGERY; HOSPITAL COST; HUMAN; IMPLANTATION; LENGTH OF STAY; MALE; MIDDLE AGED; NORWAY; PERIOPERATIVE PERIOD; REGRESSION ANALYSIS; RETROSPECTIVE STUDY; STATISTICS;

ADOLESCENT; ADULT; AGED; CARDIAC SURGICAL PROCEDURES; CHILD; FEMALE; HEART-ASSIST DEVICES; HOSPITAL COSTS; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; NORWAY; PERIOPERATIVE PERIOD; PROSTHESIS IMPLANTATION; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES;

EID: 84865331256     PISSN: None     EISSN: 17498090     Source Type: Journal    
DOI: 10.1186/1749-8090-7-76     Document Type: Article

References (25)

1. Simon MA, Kormos RL, Gorcsan J, Dohi K, Winowich S, Stanford E, Carozza L, Murali S. Differential exercise performance on ventricular assist device support. J Heart Lung Transplant 2005, 24(10):1506-1512. 10.1016/j.healun.2004.11.054, 16210122.
2. Sharples LD, Cafferty F, Demitis N, Freeman C, Dyer M, Banner N, Birks EJ, Khaghani A, Large SR, Tsui S, Caine N, Buxton M. Evaluation of the clinical effectiveness of the Ventricular Assist Device Program in the United Kingdom (EVAD UK). J Heart Lung Transplant 2007, 26(1):9-15. 10.1016/j.healun.2006.10.010, 17234511.
3. Urban M, Pirk J, Dorazilova Z, Netuka I. How does successful bridging with ventricular assist device affect cardiac transplantation outcome?. Interact Cardiovasc Thorac Surg 2011, 13(4):405-409. 10.1510/icvts.2011.273722, 21788304.
4. Takayama H, Naka Y, Kodali SK, Vincent JA, Addonizio LJ, Jorde UP, Williams MR. A novel approach to percutaneous right-ventricular mechanical support. Eur J Cardiothorac Surg 2012, 41(2):423-426. 10.1016/j.ejcts.2011.05.041, 21737292.
5. Mishra V, Geiran O, Fiane AE, Sørensen G, Andresen S, Olsen EK, Khushi I, Hagen TP. Costs and reimbursement gaps after implementation of third-generation left ventricular assist devices. J Heart Lung Transplant 2010, 29(1):72-78. 10.1016/j.healun.2009.06.029, 19783175.
6. Classification of surgical procedures, clinical procedure code system guidelines Trondheim permission from Nordic Medico-Statistical Committee NOMESCO Classification of Surgical Procedures (NCSP) version 1.14.:2009 http://www.helsedirektoratet.no/vp/multimedia/archive/00269/Ncsp_1_14_269099a.pdf, Classification of surgical procedures, clinical procedure code system guidelines Trondheim.
7. Nordic Centre for Classifications in Health Care- Uppsala Sweden Nord DRG 2010 NOR Classic (Norway) http://www.norddrg.net/norddrgmanual/NordDRG_2010_NOR/index.htm , Nordic Centre for Classifications in Health Care- Uppsala Sweden.
8. Activity based financing price list 2010 Oslo Ministry of health and care services http://www.helsedirektoratet.no/vp/multimedia/archive/00274/Regelverk_innsatsst_274039a.pdf, Activity based financing price list 2010.
9. Moskowitz AJ, Rose EA, Gelijns AC. The cost of long-term LVAD implantation. Ann Thorac Surg 2001, 7(3 Suppl):S195-S198. discussion S203-4.
10. Slaughter MS, Bostic R, Tong K, Russo M, Rogers JG. Temporal changes in hospital costs for left ventricular assist device implantation. J Card Surg 2011, 26(5):535-541. 10.1111/j.1540-8191.2011.01292.x, 21848578.
11. Miller LW, Nelson KE, Bostic RR, Tong K, Slaughter MS, Long JW. Hospital costs for left ventricular assist devices for destination therapy: lower costs for implantation in the post-REMATCH era. J Heart Lung Transplant 2006, 25(7):778-784. 10.1016/j.healun.2006.03.010, 16818120.
12. Moerer O, Plock E, Mgbor U, Schmid A, Schneider H, Wischnewsky MB, Burchardi H. A German national prevalence study on the cost of intensive care: an evaluation from 51 intensive care units. Crit Care 2007, 11(3):R69. 10.1186/cc5952, 2206435, 17594475.
13. McLaughlin AM, Hardt J, Canavan JB, Donnelly MB. Determining the economic cost of ICU treatment: a prospective "micro-costing" study. Intensive Care Med 2009, 35(12):2135-2140. 10.1007/s00134-009-1622-1, 19756509.
14. Lietz K, Long JW, Kfoury AG, Slaughter MS, Silver MA, Milano CA, Rogers JG, Miller LW, Deng M, Naka Y, Mancini D. Impact of center volume on outcomes of left ventricular assist device implantation as destination therapy: analysis of the Thoratec HeartMate Registry, 1998 to 2005. Circ Heart Fail 2009, 2(1):3-10. 10.1161/CIRCHEARTFAILURE.108.796128, 19808309.
15. Ruel M, Dickie S, Chow BJ, Labinaz M. Interventional valve surgery: building a team and working together. Semin Thorac Cardiovasc Surg 2010, 22(2):145-149. Review, 10.1053/j.semtcvs.2010.09.008, 21092892.
16. Wendler O, Walther T, Schroefel H, Lange R, Treede H, Fusari M, Rubino P, Thomas M. The SOURCE Registry: what is the learning curve in trans-apical aortic valve implantation?. Eur J Cardiothorac Surg 2011, 39(6):853-859. discussion 859-60. Epub 2010 Dec 22, 10.1016/j.ejcts.2010.11.018, 21183357.
17. Lurz P, Coats L, Khambadkone S, Nordmeyer J, Boudjemline Y, Schievano S, Muthurangu V, Lee TY, Parenzan G, Derrick G, Cullen S, Walker F, Tsang V, Deanfield J, Taylor AM, Bonhoeffer P. Percutaneous pulmonary valve implantation: impact of evolving technology and learning curve on clinical outcome. Circulation 2008, 117(15):1964-1972. 10.1161/CIRCULATIONAHA.107.735779, 18391109.
18. Obremskey WT, Dail T, Jahangir AA. Value-based Purchasing of Medical Devices. Clin Orthop Relat Res 2011,
19. Haneya A, Philipp A, Puehler T, Rupprecht L, Kobuch R, Hilker M, Schmid C, Hirt SW. Temporary percutaneous right ventricular support using a centrifugal pump in patients with postoperative acute refractory right ventricular failure after left ventricular assist device implantation. Eur J Cardiothorac Surg 2012, 41(1):219-223.
20. Esmore D, Kaye D, Spratt P, et al. A prospective, multicenter trial of the VentrAssist left ventricular assist device for bridge to transplant: safety and efficacy. J Heart Lung Transplant 2008, 27:579-88. 10.1016/j.healun.2008.02.012, 18503955.
21. Moreno SG, Novielli N, Cooper NJ. Cost-effectiveness of the implantable HeartMate II left ventricular assist device for patients awaiting heart transplantation. J Heart Lung Transplant 2012, 31(5):450-8. 10.1016/j.healun.2011.10.017, 22115674.
22. Sharples LD, Dyer M, Cafferty F, Demiris N, Freeman C, Banner NR, Large SR, Tsui S, Caine N, Buxton M. Cost-effectiveness of ventricular assist device use in the United Kingdom: results from the evaluation of ventricular assist device programme in the UK (EVAD-UK). J Heart Lung Transplant 2006, 25(11):1336-43. 10.1016/j.healun.2006.09.011, 17097498.
23. Rogers JG, Bostic RR, Tong KB, Adamson R, Russo M, Slaughter MS. Cost-Effectiveness Analysis of Continuous Flow Left Ventricular Assist Devices as Destination Therapy. Circ Heart Fail 2012, 5(1):10-6. 10.1161/CIRCHEARTFAILURE.111.962951, 22052901.
24. Messori A, Trippoli S, Bonacchi M, Sani G. s Left ventricular assist device as destination therapy: application of the payment-by-results approach for the device reimbursement. J Thorac Cardiovasc Surg 2009, 138(2):480-5. 10.1016/j.jtcvs.2009.02.016, 19619799.
25. Activity based financing price list 2012 Oslo Ministry of health and care services http://www.helsedirektoratet.no/publikasjoner/regelverk-innsatsstyrt-finansiering-2012/Publikasjoner/regelverk-innsatsstyrt-finansiering-2012.pdf, Activity based financing price list 2012.